Skip to main content
. 2022 Mar 16;10(3):e003635. doi: 10.1136/jitc-2021-003635

Table 3.

Tumor downstaging rates

Clinical stage before treatment Pathology stage after operation No. (%)
T stage
 cT3 ypT0 3 (8.3)
ypT1 3 (8.3)
ypT2 2 (5.6)
ypT3 3 (8.3)
 cT4 ypT0 4 (11.1)
ypT1 5 (13.9)
ypT2 5 (13.9)
ypT3 5 (13.9)
ypT4a 6 (16.7)
N stage
 cN0 ypN0 2 (5.6)
 cN1 ypN0 14 (38.9)
ypN1 1 (2.8)
ypN2 1 (2.8)
ypN3 2 (5.6)
 cN2 ypN0 6 (16.7)
ypN1 4 (11.1)
ypN2 2 (5.6)
ypN3 3 (8.3)
 cN3 ypN0 1 (2.8)
Overall tumor, node, metastases stage
 IIB I 2 (5.6)
 III 0 7 (19.4)
I 12 (33.3)
II 6 (16.7)
III 9 (25.0)